GOSSGossamer Bio, Inc.
0.1547USD-1.21%Mkt Cap: 75.62M $P/E: —3d ago
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap75.62M $
Enterprise Value60.04M $
Revenue (TTM)53.29M $
Gross Profit53.29M $
Net Income (TTM)-170.37M $
Revenue/Share0.2100 USD
Last Price0.1547 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees161
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS38341P1021
Valuation
P/E (Trailing)—
P/E (Forward)-0.87
PEG—
EV/EBITDA-0.38
EV/Revenue1.13
P/S1.44
P/B-0.23
EPS (TTM)-0.67
EPS (Forward)-0.18
52W Range
0.11381% of range3.870
52W High3.870 USD
52W Low0.1138 USD
Profitability
Gross Margin100.00%
Oper. Margin-282.25%
EBITDA Margin-297.63%
Profit Margin-351.49%
ROE138.78%
ROA-98.91%
Growth
Revenue Growth-19.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-171.27M $
CapEx (TTM)79.00K $
FCF Margin-55.86%
FCF Yield-39.36%
Net Debt-16.96M $
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity-1.65
Current Ratio0.53
Quick Ratio0.46
Book Value/Sh-0.6880 USD
Cash/Share0.1170 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.656 USD
Upside (mean)+970.5%
Target Range0.2800 USD – 4.000 USD
$0.2800+970.5% to mean$4.000
# Analysts5
Ownership
Shares Out.488.85M
Float300.97M
Insiders1.52%
Institutions86.98%
Short Interest
Short Ratio2.2d
Short % Float19.71%
Short % Out.19.43%
Shares Short94.99M
Short (prev mo.)53.70M
Technical
SMA 500.1675 (-7.6%)
SMA 2001.236 (-87.5%)
Beta2.01
S&P 52W Chg18.16%
Avg Vol (30d)36.89M
Avg Vol (10d)11.49M
Technical Indicators
RSI (14)44.0
MACD-0.0052
MACD Signal-0.0027
MACD Hist.-0.0025
BB Upper0.2116 USD
BB Middle0.1719 USD
BB Lower0.1322 USD
BB Width46.20%
ATR (14)0.0202 USD
Vol Ratio (20d)3.32x